Harry Glorikian

The Harry Glorikian Show

Health EN ↓ 141 episodes

At The Harry Glorikian Show, I, Harry Glorikian, am your host. In short, I have talks with leaders in the healthcare & life sciences industry about the ongoing data-driven transformation of their industry. From new ways to diagnose & treat patients, bring down costs & creating new value, all the way to AI algorithms that increase efficiency & accuracy, better data is revolutionizing healthcare. I turn to doctors, hospital administrators, IT directors, entrepreneurs, & others for help mapping out the changes & their impact on everyone from patients to researchers. Welcome to the show!

Author

Harry Glorikian

Category

Health

Podcast website

www.glorikian.com

Latest episode

Jul 15, 2025

Where to listen?

Podcasts in the app Replaio Radio Coming soon

Podcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts

Get it on Google Play Install for free Android almost 10M downloads · 4.8 rating iOS soon

Episodes

Wim Van Hecke on Using AI to Quantify Changes in the Brain 18.12.2018

Harry talks with Wim Van Hecke, the founder and CEO of Icometrix—builder of a cloud-based AI platform for analyzing brain MRI and CT scans—to find out how the startup's FDA-cleared technology is changing the way radiologists and other physicians interpret neuroimaging data. Please rate and review The Harry Glorikian Show on Apple Podcasts !  Here's how to do that from an iPhone, iPad, or iPod touc...

Robert Green on the Impact of Individual Genomic Data 07.12.2018

Harry's guest this week, Dr. Robert Green, is a professor of medicine and genetics at Harvard Medical School and director of the Genomes To People research program at Brigham & Women's Hospital and the Broad Institute of Harvard and MIT. They dig into the individual genome, how genomic data is being used, and the impact of genomics on various stakeholders in the healthcare system. Please rate and...

Sharon Terry on Changes in Drug Discovery, Diagnostics, and the Treatment of Patients 23.11.2018

Harry talks with Sharon Terry, president and CEO of Genetic Alliance, about the way drug discovery, diagnostics , and the treatment of patience are changing. How to rate MoneyBall Medicine on iTunes with an iPhone, iPad, or iPod touch: Launch the "Podcasts" app on your device. If you can't find this app, swipe all the way to the left on your home screen until you're on the Search page. T...

Fabien Beckers on AI and the Future of Medical Imaging 16.11.2018

Today's radiologists face a deluge of data, and their work can be tedious and error-prone. But should humans even act as radiologists? It's becoming clear that computers and humans working together are better than either alone. Harry's guest this week is Fabien Beckers, CEO of Arterys , a startup creating products at the intersection of AI, the cloud, and medical imaging. Beckers has led the growt...

Wout Brusselaers: Every Patient in a Clinical Trial: How AI Can Solve One of Healthcare's Biggest (and Most Expensive) Problems (AI Biopharma Special Series Part 6) 14.11.2018

Harry speaks with Wout Brusselaers, CEO and founder of Deep6.AI , about new technology that could help find patients for clinical trials in minutes rather than months. This is Part 6 of a six-part special series recorded at the AI Applications Summit , produced in Boston by Corey Lane Partners in October 2018. How to rate MoneyBall Medicine on iTunes with an iPhone, iPad, or iPod touch: Launch the...

Guido Lanza: Can AI Prevent Failure in Drug Discovery Pipelines? (AI Biopharma Special Series Episode 5) 14.11.2018

Harry's guest is Guido Lanza, president and CEO of Numerate. Together they tackle the question: What if the introduction of AI into drug discovery allowed us to create a true learning loop? This is Part 5 of a special six-part series recorded at the AI Applications Summit , produced in Boston by Corey Lane Partners in October 2018. How to rate MoneyBall Medicine on iTunes with an iPhone, iPad, or...

Ron Alfa: To Reimagine Drug Discovery & Development, Let the Data Drive the Process (AI Biopharma Special Series Part 4) 14.11.2018

Harry asks Dr. Ron Alfa, vice president of discovery and product at Recursion Pharmaceuticals , what efficiencies could be achieved and what problems could be solved if data science were applied to drug discovery. This is Part 4 of a special six-part series recorded at the AI Applications Summit , produced in Boston by Corey Lane Partners in October 2018. Please rate and review The Harry Glorikian...

Shrujal Baxi: Is AI Ready to Solve Healthcare's Real-World Evidence Problem? (AI Biopharma Special Series Part 3) 14.11.2018

Harry's guest is Dr. Shrujal Baxi, medical director of Flatiron Health. On the agenda: how technology can help create the real-world evidence needed to achieve better patient outcomes and accelerate research into new areas. This is Part 3 of a 6-part special series recorded at the AI Applications Summit , produced in Boston by Corey Lane Partners in October 2018. Please rate and review The Harry G...

Milind Kamkolkar: Big Pharma is Paying Attention, But Can They Adapt to the AI-Driven Landscape? (AI Biopharma Special Series Part 2) 14.11.2018

In this episode Harry talks with Milind Kamkolkar, chief data officer at Sanofi, about how big pharma can start using new data sources to uncover new insights about disease. This is Part 2 of a special 6-part series of episodes recorded at the AI Applications Summit produced in Boston by Corey Lane Partners in October 2018. How to rate MoneyBall Medicine on iTunes with an iPhone, iPad, or iPod tou...

Andrew A. Radin: From Validation to Pharma Pipeline—How AI is Finding the Patterns in Data (AI Biopharma Special Series Part 1) 14.11.2018

Harry interviews Andrew A. Radin, co-founder and CEO of twoXAR , a Mountain View, CA-based AI-driven drug discovery startup that unifies disparate data to identify potential disease treatments. This episode is Part 1 of a 6-part special series recorded at the AI Applications Summit produced in Boston by Corey Lane partners in October 2018. Please rate and review The Harry Glorikian Show on Apple P...

Leah Binder on How Price and Quality Transparency Helps Patients and Employers 09.11.2018

Leapfrog Group president and CEO Leah Binder talks with Harry about data transparency and how it helps inform healthcare decisions by putting the right information in the hands of patients and employers. Please rate and review The Harry Glorikian Show on Apple Podcasts !  Here's how to do that from an iPhone, iPad, or iPod touch: 1.  Open the Podcasts app on your iPhone, iPad, or Mac. 2.  Navigate...

John Glaser and How AI is Affecting Electronic Medical Records Systems 26.10.2018

Harry's guest John Glaser, senior vice president of Population Health at Cerner, speculates on how business models in healthcare are changing and how artificial intelligence and EMR systems will work together in the future. Please rate and review The Harry Glorikian Show on Apple Podcasts !  Here's how to do that from an iPhone, iPad, or iPod touch: 1.  Open the Podcasts app on your iPhone, iPad,...

Dekel Gelbman and How Machine Learning Is Changing Rare Disease Diagnosis 12.10.2018

Harry's guest is Dekel Gelbman, founding CEO of FDNA. The company uses a combination of computer vision, deep learning, and other artificial intelligence techniques to improve and accelerate diagnostics and therapeutics for children with rare diseases. Please rate and review The Harry Glorikian Show on Apple Podcasts !  Here's how to do that from an iPhone, iPad, or iPod touch: 1.  Open the Podcas...

Jason Bhan and How AI and Machine Learning Are Enabling Early Disease Detection 01.10.2018

Jason Bhan, co-founder and chief medical officer of Prognos, joins Harry to talk about how machine learning is being used to dig into multi-sourced clinical diagnostic data to improve health by predicting disease early. Please rate and review The Harry Glorikian Show on Apple Podcasts !  Here's how to do that from an iPhone, iPad, or iPod touch: 1.  Open the Podcasts app on your iPhone, iPad, or M...

Niven Narain and How AI and Machine Learning Are Changing Drug Discovery 15.09.2018

Harry interviews Niven Narain, the co-founder, president and CEO of Berg, a Boston-based biopharma company driving the next generation of drugs and diagnostics by combining patient-driven biology and AI to unravel actionable disease insight. Narain has overseen development of Berg’s clinical stage assets and pipeline and forged strategic partnerships with industry academic and US and UK government...

Glenn Steele and How Analytics are Changing Healthcare 11.09.2018

Host Harry Glorikian talks with Dr. Glenn Steele, chairman of G. Steele Health Solutions, which helps healthcare organizations improve quality, and vice chairman of the Health Transformation Alliance, a cooperative of self-insured employers. Dr. Steele is the former chairman of XG Health Solutions and former president and CEO of Geisinger Health Systems, and he shares his views on how data and ana...

Listen to the The Harry Glorikian Show podcast in Replaio

Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch

Get it on Google Play

Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.